Partner Content Partner Content Social Listening for Pharma Companies Social Media in Pharma Conference
Events Partner Content The Return of 11th Annual Social Media in Pharma 2019 The Return of 11th Annual Social Media in Pharma 2019
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
